# Clean Energy Fuels Corp.: financial statements, quarterly

CLNE · Nasdaq · CIK 1368265 · [Utilities](/sectors/utilities.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/clne.md) · [Financials](/companies/clne/financials.md) · [Filings](/companies/clne/filings.md) · [Insiders](/companies/clne/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/clne/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [95.6](/filings/0001558370-24-014634.md) | [107 d](/filings/0001104659-26-019215.md) | [104](/filings/0001558370-25-006991.md) | [98.0](/filings/0001558370-25-010791.md) | [105](/filings/0001104659-25-106319.md) | [109 d](/filings/0001104659-26-019215.md) | [104](/filings/0001104659-26-057194.md) | [103](/filings/0001104659-26-092061.md) | [106](/filings/0001104659-25-106319.md) | [112 d](/filings/0001104659-26-019215.md) | [118](/filings/0001104659-26-057194.md) | [106](/filings/0001104659-26-092061.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | [29.1](/filings/0001558370-24-014634.md) | [25.0 d](/filings/0001104659-26-019215.md) | [26.2](/filings/0001558370-25-006991.md) | [28.3](/filings/0001558370-25-010791.md) | [28.9](/filings/0001104659-25-106319.md) | [28.4 d](/filings/0001104659-26-019215.md) | [27.5](/filings/0001104659-26-057194.md) | [27.5](/filings/0001104659-26-092061.md) | [26.3](/filings/0001104659-25-106319.md) | [30.7 d](/filings/0001104659-26-019215.md) | [24.5](/filings/0001104659-26-057194.md) | [24.6](/filings/0001104659-26-092061.md) |
| Operating income | $m | [(21.4)](/filings/0001558370-24-014634.md) | [(6.6) d](/filings/0001104659-26-019215.md) | [(9.3)](/filings/0001558370-25-006991.md) | [(5.6)](/filings/0001558370-25-010791.md) | [(8.5)](/filings/0001104659-25-106319.md) | [(12.9) d](/filings/0001104659-26-019215.md) | [(126)](/filings/0001104659-26-057194.md) | [(9.2)](/filings/0001104659-26-092061.md) | [(13.6)](/filings/0001104659-25-106319.md) | [(10.7) d](/filings/0001104659-26-019215.md) | [(2.9)](/filings/0001104659-26-057194.md) | [(5.1)](/filings/0001104659-26-092061.md) |
| Interest expense | $m | [3.9](/filings/0001558370-24-014634.md) | [10.3 d](/filings/0001104659-26-019215.md) | [7.8](/filings/0001558370-25-006991.md) | [7.9](/filings/0001558370-25-010791.md) | [8.4](/filings/0001104659-25-106319.md) | [8.1 d](/filings/0001104659-26-019215.md) | [7.5](/filings/0001104659-26-057194.md) | [7.7](/filings/0001104659-26-092061.md) | [7.8](/filings/0001104659-25-106319.md) | [29.6 d](/filings/0001104659-26-019215.md) | [5.7](/filings/0001104659-26-057194.md) | [5.5](/filings/0001104659-26-092061.md) |
| Income tax | $m | [(0.0)](/filings/0001558370-24-014634.md) | [(0.3) d](/filings/0001104659-26-019215.md) | [(0.2)](/filings/0001558370-25-006991.md) | [0.8](/filings/0001558370-25-010791.md) | [0.1](/filings/0001104659-25-106319.md) | [2.1 d](/filings/0001104659-26-019215.md) | [(2.9)](/filings/0001104659-26-057194.md) | [0.1](/filings/0001104659-26-092061.md) | [0.1](/filings/0001104659-25-106319.md) | [(0.0) d](/filings/0001104659-26-019215.md) | [0.0](/filings/0001104659-26-057194.md) | [0.1](/filings/0001104659-26-092061.md) |
| Net income | $m | [(25.8)](/filings/0001558370-24-014634.md) | [(18.7) d](/filings/0001104659-26-019215.md) | [(18.4)](/filings/0001558370-25-006991.md) | [(16.3)](/filings/0001558370-25-010791.md) | [(18.2)](/filings/0001104659-25-106319.md) | [(30.2) d](/filings/0001104659-26-019215.md) | [(135)](/filings/0001104659-26-057194.md) | [(20.2)](/filings/0001104659-26-092061.md) | [(23.8)](/filings/0001104659-25-106319.md) | [(43.0) d](/filings/0001104659-26-019215.md) | [(12.4)](/filings/0001104659-26-057194.md) | [(14.9)](/filings/0001104659-26-092061.md) |
| Diluted EPS | $ per share | [(0.12)](/filings/0001558370-24-014634.md) | not reported | [(0.08)](/filings/0001558370-25-006991.md) | [(0.07)](/filings/0001558370-25-010791.md) | [(0.08)](/filings/0001104659-25-106319.md) | not reported | [(0.60)](/filings/0001104659-26-057194.md) | [(0.09)](/filings/0001104659-26-092061.md) | [(0.11)](/filings/0001104659-25-106319.md) | not reported | [(0.06)](/filings/0001104659-26-057194.md) | [(0.07)](/filings/0001104659-26-092061.md) |
| Basic EPS | $ per share | [(0.12)](/filings/0001558370-24-014634.md) | not reported | [(0.08)](/filings/0001558370-25-006991.md) | [(0.07)](/filings/0001558370-25-010791.md) | [(0.08)](/filings/0001104659-25-106319.md) | not reported | [(0.60)](/filings/0001104659-26-057194.md) | [(0.09)](/filings/0001104659-26-092061.md) | [(0.11)](/filings/0001104659-25-106319.md) | not reported | [(0.06)](/filings/0001104659-26-057194.md) | [(0.07)](/filings/0001104659-26-092061.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: not reported
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [25.1](/filings/0001558370-23-018583.md) | [105](/filings/0001558370-25-001390.md) | [89.4](/filings/0001558370-24-007619.md) | [123](/filings/0001558370-24-011362.md) | [117](/filings/0001558370-24-014634.md) | [89.5](/filings/0001104659-26-019215.md) | [119](/filings/0001558370-25-006991.md) | [132](/filings/0001558370-25-010791.md) | [181](/filings/0001104659-25-106319.md) | [156](/filings/0001104659-26-092061.md) | [55.5](/filings/0001104659-26-057194.md) | [57.0](/filings/0001104659-26-092061.md) |
| Current assets | $m | [393](/filings/0001558370-23-018583.md) | [470](/filings/0001558370-25-001390.md) | [449](/filings/0001558370-24-007619.md) | [451](/filings/0001558370-24-011362.md) | [442](/filings/0001558370-24-014634.md) | [414](/filings/0001104659-26-019215.md) | [409](/filings/0001558370-25-006991.md) | [408](/filings/0001558370-25-010791.md) | [409](/filings/0001104659-25-106319.md) | [350](/filings/0001104659-26-092061.md) | [332](/filings/0001104659-26-057194.md) | [324](/filings/0001104659-26-092061.md) |
| Total assets | $m | [1,065](/filings/0001558370-23-018583.md) | [1,259](/filings/0001558370-25-001390.md) | [1,236](/filings/0001558370-24-007619.md) | [1,246](/filings/0001558370-24-011362.md) | [1,244](/filings/0001558370-24-014634.md) | [1,244](/filings/0001104659-26-019215.md) | [1,117](/filings/0001558370-25-006991.md) | [1,116](/filings/0001558370-25-010791.md) | [1,125](/filings/0001104659-25-106319.md) | [1,057](/filings/0001104659-26-092061.md) | [1,037](/filings/0001104659-26-057194.md) | [1,026](/filings/0001104659-26-092061.md) |
| Current liabilities | $m | [146](/filings/0001558370-23-018583.md) | [164](/filings/0001558370-25-001390.md) | [143](/filings/0001558370-24-007619.md) | [142](/filings/0001558370-24-011362.md) | [144](/filings/0001558370-24-014634.md) | [155](/filings/0001104659-26-019215.md) | [145](/filings/0001558370-25-006991.md) | [144](/filings/0001558370-25-010791.md) | [152](/filings/0001104659-25-106319.md) | [151](/filings/0001104659-26-092061.md) | [135](/filings/0001104659-26-057194.md) | [131](/filings/0001104659-26-092061.md) |
| Total liabilities | $m | [373](/filings/0001558370-23-018583.md) | [526](/filings/0001558370-25-001390.md) | [507](/filings/0001558370-24-007619.md) | [517](/filings/0001558370-24-011362.md) | [513](/filings/0001558370-24-014634.md) | [524](/filings/0001104659-26-019215.md) | [514](/filings/0001558370-25-006991.md) | [519](/filings/0001558370-25-010791.md) | [534](/filings/0001104659-25-106319.md) | [492](/filings/0001104659-26-092061.md) | [473](/filings/0001104659-26-057194.md) | [467](/filings/0001104659-26-092061.md) |
| Long-term debt | $m | [145](/filings/0001558370-23-018583.md) | [261](/filings/0001558370-25-001390.md) | [262](/filings/0001558370-24-007619.md) | [263](/filings/0001558370-24-011362.md) | [264](/filings/0001558370-24-014634.md) | [265](/filings/0001104659-26-019215.md) | [272](/filings/0001558370-25-006991.md) | [278](/filings/0001558370-25-010791.md) | [284](/filings/0001104659-25-106319.md) | [227](/filings/0001104659-26-092061.md) | [228](/filings/0001104659-26-057194.md) | [229](/filings/0001104659-26-092061.md) |
| Current portion of debt | $m | [0.0](/filings/0001558370-23-018583.md) | [0.0](/filings/0001558370-25-001390.md) | [0.0](/filings/0001558370-24-007619.md) | [0.0](/filings/0001558370-24-011362.md) | [0.0](/filings/0001558370-24-014634.md) | [0.0](/filings/0001104659-26-019215.md) | [0.0](/filings/0001558370-25-006991.md) | [0.0](/filings/0001558370-25-010791.md) | [0.1](/filings/0001104659-25-106319.md) | [0.1](/filings/0001104659-26-092061.md) | [0.1](/filings/0001104659-26-057194.md) | [0.1](/filings/0001104659-26-092061.md) |
| Shareholders' equity | $m | [685](/filings/0001558370-23-018583.md) | [727](/filings/0001558370-25-001390.md) | [723](/filings/0001558370-24-007619.md) | [723](/filings/0001558370-24-011362.md) | [725](/filings/0001558370-24-014634.md) | [713](/filings/0001104659-26-019215.md) | [597](/filings/0001558370-25-006991.md) | [591](/filings/0001558370-25-010791.md) | [585](/filings/0001104659-25-106319.md) | [559](/filings/0001104659-26-092061.md) | [558](/filings/0001104659-26-057194.md) | [553](/filings/0001104659-26-092061.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [7.7 d](/filings/0001558370-24-014634.md) | [43.0 d](/filings/0001104659-26-019215.md) | [2.6](/filings/0001558370-25-006991.md) | [18.8 d](/filings/0001558370-25-010791.md) | [21.4 d](/filings/0001104659-25-106319.md) | [21.9 d](/filings/0001104659-26-019215.md) | [23.4](/filings/0001104659-26-057194.md) | [35.9 d](/filings/0001104659-26-092061.md) | [13.1 d](/filings/0001104659-25-106319.md) | [13.1 d](/filings/0001104659-26-019215.md) | [(8.4)](/filings/0001104659-26-057194.md) | [28.8 d](/filings/0001104659-26-092061.md) |
| Capital expenditure | $m | [24.5 d](/filings/0001558370-24-014634.md) | [33.6 d](/filings/0001104659-26-019215.md) | [18.2](/filings/0001558370-25-006991.md) | [13.9 d](/filings/0001558370-25-010791.md) | [21.3 d](/filings/0001104659-25-106319.md) | [11.5 d](/filings/0001104659-26-019215.md) | [7.5](/filings/0001104659-26-057194.md) | [5.0 d](/filings/0001104659-26-092061.md) | [6.6 d](/filings/0001104659-25-106319.md) | [6.6 d](/filings/0001104659-26-019215.md) | [6.9](/filings/0001104659-26-057194.md) | [3.6 d](/filings/0001104659-26-092061.md) |
| Share repurchases | $m | [0.0 d](/filings/0001558370-23-018583.md) | [0.0 d](/filings/0001104659-26-019215.md) | [0.0](/filings/0001558370-25-006991.md) | [0.0 d](/filings/0001558370-25-010791.md) | [0.0 d](/filings/0001104659-25-106319.md) | [0.0 d](/filings/0001104659-26-019215.md) | [0.4](/filings/0001104659-26-057194.md) | [7.5 d](/filings/0001104659-26-092061.md) | [0.0 d](/filings/0001104659-25-106319.md) | [0.0 d](/filings/0001104659-26-019215.md) | [0.0](/filings/0001104659-26-057194.md) | [0.0 d](/filings/0001104659-26-092061.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [222](/filings/0001558370-23-018583.md) | [223](/filings/0001558370-24-007619.md) | [223](/filings/0001558370-24-011362.md) | [223](/filings/0001558370-24-014634.md) | [223](/filings/0001558370-25-006991.md) | [223](/filings/0001558370-25-010791.md) | [223](/filings/0001104659-25-106319.md) | [224](/filings/0001104659-26-057194.md) | [220](/filings/0001104659-26-092061.md) | [219](/filings/0001104659-25-106319.md) | [220](/filings/0001104659-26-057194.md) | [220](/filings/0001104659-26-092061.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 220,445,015 at 2026-07-30, from the cover of the [10-Q filed 2026-08-06](/filings/0001104659-26-092061.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:37 ET. No prices; not investment advice.